Share

Cold sore virus vs. cancer

A modified version of the virus that causes cold sores is showing early promise in targeting colorectal and liver cancer cells, scientists report.

The herpes simplex virus is specially designed so that it grows in specific cancer cells, killing them in the process. The researchers report that the genetically altered virus is safe for healthy tissue.

The findings were presented on July 7 at the annual European Society for Medical Oncology meeting in Lugano, Switzerland.

"It doesn't replicate in normal, healthy cells, so our hope is that it will help fight cancers without causing side effects in the rest of the body," Dr Axel Mescheder, vice president of clinical research and development for MediGene, said in a prepared statement. MediGene is a German biotech company based in Munich.

Mescheder reported safety and efficacy results and described the case of a patient whose liver tumours appeared to be reduced six months after treatment with the virus.

Seven leading cancer centres in the United States are participating in the study.

Almost 40 percent of patients with colorectal cancer die, because cancer spreads to other parts of the body, particularly the liver. The results reported by Mescheder follow testing in the lab and in animals, where the virus was shown to be effective at killing colorectal cancer and liver cancer cells. – (HealthDayNews)

Read more:
Cancer Centre

July 2007

We live in a world where facts and fiction get blurred
Who we choose to trust can have a profound impact on our lives. Join thousands of devoted South Africans who look to News24 to bring them news they can trust every day. As we celebrate 25 years, become a News24 subscriber as we strive to keep you informed, inspired and empowered.
Join News24 today
heading
description
username
Show Comments ()
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE